share_log

HC Wainwright & Co. Maintains Buy on BioCardia, Lowers Price Target to $4

Benzinga ·  Sep 6, 2023 10:50

HC Wainwright & Co. analyst Joseph Pantginis maintains BioCardia (NASDAQ:BCDA) with a Buy and lowers the price target from $9 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment